Kaneka Nutrients announces The International Coenzyme Q10 Association Ninth Scientific Meeting

Food and Healthcare Press Releases Tuesday November 14, 2017 09:07
PASADENA, Texas--14 Nov--PRNewswire/InfoQuest
June 21-24, 2018 at Columbia University, NYC

The International Coenzyme Q10 Association (ICQA; http://icqaproject.org/ ) is a non-profit organization that fosters basic and applied biomedical research on Coenzyme Q10 (CoQ10). Their mission is to advance knowledge on basic biochemistry and molecular genetics, as well as preventive and therapeutic effects of CoQ10.   Kaneka Nutrients ( www.kanekanutrients.com ) is a founding member and proud to partner with ICQA for the Ninth Scientific Meeting to be held in at Columbia University in New York City June 21 – 24, 2018.

"We have not held our Scientific Meeting in the United States in over 10 years.   As such, we are excited to bring this meeting back to the United States.   Previous Scientific Meetings have been held in Japan and Europe," said Dr. Placido Navas, Chairman of The International Coenzyme Q10 Association.

Every two to three years, nearly 350+ researchers and other professionals choose to attend the ICQA International Scientific Meeting to learn about the latest advances of Conventional CoQ10 and the Ubiquinol form of CoQ10, meet with colleagues from around the world and strike new collaborations.

The critical goals of the ICQA are to promote international collaborative research efforts to expand scientific knowledge and to optimize the use of CoQ10 as preventative and therapeutic interventions in human health. To achieve these important goals, ICQA organizes an international scientific meeting to present cutting-edge CoQ10 and Ubiquinol CoQ10 research in major clinical topics including: mitochondrial and degenerative diseases, aging, cardiovascular disorders, and nutritional supplementation needs and mechanisms that can benefit people suffering these conditions.

Dr. Navas added, "As in the 2015 Bologna Scientific Meeting, exciting sessions on the areas of CoQ10 and Ubiquinol CoQ10 research that have advanced significantly in the last few years will be presented including: mitochondrial diseases (primarily CoQ10 deficiency syndrome), cardiovascular diseases, diabetes, and aging. There is evidence of efficacy of CoQ10 supplementation in these conditions. Significantly, the European Medicines Agency has recently registered Ubiquinol as an orphan drug for CoQ10 deficiency syndrome."

Mark your calendars for this important Scientific Meeting to learn about the advances of Conventional CoQ10 and the Ubiquinol form of CoQ10.   Visit icqaproject.org for more information and to register.
Contact Information:
Ron Martin
Kaneka Nutrients
+1-281-291-3185

Latest Press Release

Boehringer Ingelheim has a very successful 2017 financial year

- Sharp increase in net sales to nearly 18.1 billion euros (+15.7 per cent in currency-adjusted terms; +13.9 per cent in euro terms) - Operating income rises significantly to around 3.5 billion euros - Return on net sales of 19.3 per cent - Strengthened...

Merck Receives Patent for CRISPR Technology in China

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards -...

Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in the UK

- Centre will 'bridge the gap' between scientific research and commercialisation of the medicines of the future - Over GBP60 million of Industrial Strategy investment is being used to develop the new centre Today,the Cell and Gene Therapy Catapult's...

Creation of Inceptua Clinical Trial Services Marks New Era for the Company

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines...

FDI White Paper and Practical Guide Address the Global Burden of Periodontal Disease

FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. (Logo:...

Related Topics